Glutathione concentration, glutathione peroxidase and glutathione reductase activity in elderly patients with type II diabetes compared to hypertensives
DOI:
https://doi.org/10.12775/CL.2010.004Abstract
Age-related oxidative stress is generated by a combination of increased production of free radicals, decreased antioxidants levels, diminished activity of antioxidant enzymes and impaired repair of oxidative damages. Oxidative stress is associated with many diseases commonly present in elderly such as hypertension and diabetes. In our study we have observed significantly (p<0,01) increased level of reduced glutathione in treated hypertensive compared to treated diabetic patients (3,1± 0,29 mmol/L and 2,72 ± 0,4 mmol/L, respectively) and significantly (p<0,01) increased activity of glutathione reductase (83,43± 15,25 U/g Hb and 65,74 ± 14,27 U/g Hb, respectively).
References
D. Harman, “Aging: A theory based on free radical and radiation chemistry.” J Gerontol 1956; 11: s. 298-300.
D. Harman, “Free radical theory of aging: An update: Increasing the functional life span.” Ann N Y Acad Sci 2006; 1067: s. 10- 21.
M. Valko, “Free radicals and antioxidants in normal physiological functions and human disease.” Int J Biochem Cell Bi 2007; 39: s. 44–84.
A. Ceriello, “Possible role of oxidative stress in the pathogenesis of hypertension.” Diabetes Care 2008 ; 31(Suppl 2): s. 181–184.
G. Csányi, R.W. Taylor, P.J. Pagano, “Nox and inflammation in the vascular adventitia.” Free Radic Biol Med 2009; 47: s. 1254-1266.
J. Pedro-Botet, M. Covas, S. Martin and J. Rubies-Prat, “Decreased endogenous antioxidant enzymatic status in essential hypertension.” J Hum Hypertens 2000; 14(6): s. 343-345.
K. Kędziora-Kornatowska, H. Pawluk, T. Kornatowski, L. Szadujkis-Szadurski, J. Czuczejko, K. Szewczyk-Golec, J. Motyl, J. Kędziora, „Peroksydacja lipidów a glutationozależna obrona antyoksydacyjna u chorych z cukrzycą typu 2 w wieku podeszłym.” Geriatr Pol 2006; 3: s. 183-189.
I.B. Afanas’ev, “Free radical mechanism of aging processes under physiological conditions.” Biogerontology 2005; 6(4): s. 283-290.
G. Donmez, U. Derici, D. Erbas, T. Arinsoy, A. Onk, S. Sindel and E. Hasanoglu, “The effects of losartan and enalapril therapies on levels of nitric oxide, malondialdehde, and glutathione in patients with essential hypertension.” Jpn J Physol 2002; 2: s. 435- 440.
K. Kędziora-Kornatowska, K. Szewczyk-Golec, J. Czuczejko, H. Pawluk, K. van Marke de Lumen , M. Kozakiewicz, G. Bartosz, J. Kędziora, “Antioxidative effects of melatonin administration in elderly primary essential hypertension patients.” J Pineal Res 2008; 45(3): s. 312 – 317.
G. Bartosz, „Druga twarz tlenu.” PWN, Warszawa, 2003, pp. 13-14
R. Franco, O.J. Schoneveld , A. Pappa, M.I. Panayiotidis, “The central role of glutathione in the pathophysiology of human diseases.” Arch Physiol Biochem 2007; 113(4-5): s. 234-258.
G. Wu, Y.Z. Fang, S. Yang, J.R. Lupton, N.D. Turner, “Glutathione metabolism and its implications for health.” J Nutr 2004; 134: s. 489-492.
L. Ghiadoni, A. Magagna, D. Versari, I. Kardasz, Y. Huang, S. Taddei, A. Salvetti, “Different Effect of Antihypertensive Drugs on Conduit Artery Endothelial Function.” Hypertension 2003; 41: s. 1281-1286.
E. Grossman, “Does increased oxidative stress cause hypertension.” Diabetes Care 2008; 31( Suppl. 2): s. 185-189.
N.C. Ward, J.M. Hodgson, I.B. Puddey, T.A. Mori, L.J. Beilin, K.D. Croft, “Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle.” Free Radic Biol Med 2004; 36(2): s. 226-232.
S. Wassmann, K. Wassmann, G. Nickenig, “Modulation of oxidant and antioxidant enzymes expression and function in vascular cells.” Hypertension 2004; 44: s. 381-386.
R. Rodrigo, H. Prat, W. Passalacqua, J. Araya, C. Guichard, J.P. Bächler, “Relationship between oxidative stress and essential hypertension.” Hypertens Res 2007; 30(12): s. 1159-1167.
G. Wu, Y.Z. Fang, S. Yang, J.R. Lupton, N.D. Turner, “Glutathione metabolism and its implications for health.” J Nutr 2004; 134: s. 489-492
R.M. Uppu, B.D. Nossaman, A.J. Greco, A. Fokin, S.N. Murthy, V.A. Fonseca, P.J. Kadowitz, “Cardiovascular effect of peroxynitrite.” Clin Exp Pharmacol Physiol 2007; 34: s. 933–937.
D.R. Noble, H.R. Swift and D.L.H. Williams, “Nitric oxide release from Snitrosoglutathione (GSNO).” Chem Commun 1999; 22: s. 2317–2318.
M. Sedeek, R.L. Hebert, C.R. Kennedy, K.D. Burns, R.M. Touyz, “Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.” Curr Opin Nephrol Hypertens 2009; 18(2): s. 122- 127.
J. Redón, M.R. Oliva, C. Tormos, V. Giner, J. Chaves, “Antioxidant activities and oxidative stress byproducts in human hypertension.” Hypertension 2003; 41(5): s. 1096-1101.
E. Szaleczky, J. Prechl, J. Fehér, A. Somogyi, “Alterations in enzymatic antioxidant defence in diabetes mellitus − a rational approach.”Postgrad Med J 1999; 75: s. 13-17.
E.B. Bolajoko, K.S. Mossanda, F. Adeniyi, O. Akinosun, A. Fasanmade, M. Moropane, “Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer.” S Afr Med J 2008; 98(8): s. 614- 617.
J.E. Freedman, F. Balz, G.N. Welch, J. Loscalzo, “Glutathione peroxidase potentiates the inhibition of platelet function by S-Nitrosothiols.” J Clin Invest 1995; 96: s. 394-400.
X.G. Lei, W.H. Cheng and J.P. McClung, “Metabolic regulation and function of glutathione peroxidase-1.” Annu Rev Nutr 2007; 27: s. 41-61.
Downloads
Published
How to Cite
Issue
Section
Stats
Number of views and downloads: 290
Number of citations: 0